Assessment of immune correlates of melanoma vaccine

$61,783P30FY2000ARNIH

Emory University, Atlanta GA

Investigators

Linked publications & trials

Paper 31477684 Paper 28825045 Paper 28275008 Paper 27438151 Paper 27438140 Paper 27164914 Paper 26902127 Paper 26896643 Paper 26871475 Paper 24518113 Paper 24363504 Paper 24118276 Paper 23677514 Paper 22794825 Paper 22581366 Paper 22418874 Paper 22378045 Paper 22353783 Paper 21873987 Paper 21566577 Paper 21167418 Paper 21079051 Paper 20708478 Paper 19863376 Paper 19751888 Paper 19737291 Paper 19615548 Paper 19451506 Paper 19256307 Paper 19209155 Paper 19022100 Paper 18950288 Paper 18794083 Paper 18787531 Paper 18713055 Paper 18710373 Paper 18640101 Paper 18594009 Paper 18550210 Paper 18370913 Paper 18342722 Paper 18173524 Paper 18087002 Paper 18076590 Paper 17445948 Paper 17438183 Paper 17308088 Paper 17214673 Paper 17141364 Paper 17052484 Paper 16983325 Paper 16912072 Paper 16741507 Paper 16614726 Paper 16397520 Paper 16301410 Paper 16098028 Paper 15854019 Paper 15813746 Paper 15624555 Paper 15611471 Paper 15456899 Paper 15304078 Paper 15254208 Paper 15210467 Paper 15153883 Paper 15086340 Paper 15083784 Paper 14739520 Paper 14734752 Paper 14730344 Paper 14708625 Paper 14708586 Paper 14610056 Paper 14507641 Paper 12960139 Paper 12816951 Paper 12808046 Paper 12789178 Paper 12713595 Paper 12626512 Paper 12603864 Paper 12426320 Paper 12213705 Paper 12176738 Paper 11862172 Paper 11805326 Paper 11680567 Paper 11606920 Paper 11602857 Paper 11511849 Paper 11511840 Paper 11485907 Paper 11336682 Paper 11174372 Paper 11106566 Paper 10827398 Paper 10751370 Paper 10706695

Abstract

To introduce the new and robust technology of MHC class I tetramers for the quantification of immune responses in melanoma patients involved in a multi-institutional phase III clinical trial. Recent evidence suggests that circulating CD8+ T cells in melanoma patients may be present in relatively large numbers but may be impotent. Therefore, we will assess the functional potential of melanoma-specific CD8+ T cells by examining their response to peptide stimulation using a combination of MHC tetramer staining, together with analysis of intracellular cytokine production.

View original record on NIH RePORTER →